Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
9138studies shown
Showing 426-450 of 9,138
CompletedNCT05841030

A Study in people with Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

This study is completed in multiple countries, including in Argentina, in Brazil, and in Canada. It focuses on depression.

DepressionOtherFrom 18 Years to 74 Years
Countries
Argentina, Brazil, Canada, France, Germany, Italy, South Korea, Spain, Sweden, United Kingdom, United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Active Not RecruitingNCT03642964

A Study in people with Major Depressive Disorder

This study is comparing CTC-501 with placebo for people with depression. Participants receive CTC-501 or placebo and complete study visits and assessments.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Chase Therapeutics Corporation
Condition
Depression
TerminatedNCT05518149

Aticaprant in Adult and Elderly people with Major Depressive Disorder (MDD)

This study has public registry information in multiple countries, including in Argentina, in Australia, and in Belgium. It is testing aticaprant for depression.

DepressionOtherFrom 18 Years to 74 Years
Countries
Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, France, Hungary, Italy, Poland, Portugal, Slovakia, South Africa, South Korea, Spain, Sweden, Taiwan, United Kingdom, United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
RecruitingNCT07412756

Brenipatide in adults with Major Depressive Disorder

This study is recruiting in multiple countries, including in Australia, in Brazil, and in Canada. It is testing brenipatide for depression.

DepressionOtherFrom 18 Years to 75 Years
Countries
Australia, Brazil, Canada, China, Germany, Greece, Japan, Mexico, Poland, United States, South Korea, Spain, Taiwan, United Kingdom
Sponsor
Eli Lilly and Company
Condition
Depression
RecruitingNCT07053345

Esketamine Nasal Spray for depression

This study is recruiting in South Korea. It is testing esketamine Nasal Spray for depression.

DepressionOtherFrom 18 Years to 64 Years
Countries
South Korea
Sponsor
Janssen Korea, Ltd., Korea
Condition
Depression
RecruitingNCT06793397

A Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

This study is recruiting in multiple countries, including in Australia, in Czech Republic, and in Germany. It is testing a Deuterated Psilocin Analog for depression.

DepressionOtherFrom 18 Years to 85 Years
Countries
Australia, Czech Republic, Germany, Greece, Ireland, Poland, United Kingdom, United States
Sponsor
Cybin IRL Limited
Condition
Depression
Mental Health | Clinical Trials | HopeStage Research